Jesús Prìeto

31.2k total citations · 3 hit papers
606 papers, 24.6k citations indexed

About

Jesús Prìeto is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Jesús Prìeto has authored 606 papers receiving a total of 24.6k indexed citations (citations by other indexed papers that have themselves been cited), including 219 papers in Molecular Biology, 193 papers in Hepatology and 168 papers in Epidemiology. Recurrent topics in Jesús Prìeto's work include Liver Disease Diagnosis and Treatment (102 papers), Virus-based gene therapy research (102 papers) and Hepatitis C virus research (81 papers). Jesús Prìeto is often cited by papers focused on Liver Disease Diagnosis and Treatment (102 papers), Virus-based gene therapy research (102 papers) and Hepatitis C virus research (81 papers). Jesús Prìeto collaborates with scholars based in Spain, United States and Germany. Jesús Prìeto's co-authors include Bruno Sangro, Cheng Qian, Ignacio Melero, Jorge Quiroga, Matías A. Ávila, Carmen Berasain, Juan José Lasarte, Pablo Sarobe, Francisco Borrás‐Cuesta and Alberto Castilla and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Jesús Prìeto

593 papers receiving 24.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

2013 764 citations Bruno Sangro, José Ignacio Riezu‐Boj et al. profile →
Transforming Growth Factors β1 and α in Chronic Liver Disease

1991 563 citations Jesús Prìeto et al. profile →
Immunological landscape and immunotherapy of hepatocellular carcinoma

2015 470 citations Jesús Prìeto, Ignacio Melero et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jesús Prìeto	8.7k	7.9k	6.8k	6.0k	5.0k	606	24.6k
Robert F. Schwabe	8.7k 1.0×	8.5k 1.1×	10.4k 1.5×	3.7k 0.6×	3.8k 0.8×	130	24.3k
Norio Hayashi	11.6k 1.3×	7.9k 1.0×	7.9k 1.2×	2.3k 0.4×	4.8k 1.0×	623	26.4k
Tsutomu Chiba	8.0k 0.9×	2.6k 0.3×	4.4k 0.7×	4.5k 0.8×	4.2k 0.8×	603	24.2k
Geoffrey W. McCaughan	3.1k 0.4×	8.7k 1.1×	8.4k 1.2×	4.7k 0.8×	3.4k 0.7×	528	20.3k
John P. Iredale	5.1k 0.6×	11.0k 1.4×	8.7k 1.3×	2.2k 0.4×	3.9k 0.8×	176	21.3k
Atsushi Miyajima	10.3k 1.2×	3.3k 0.4×	1.9k 0.3×	8.7k 1.5×	10.2k 2.0×	364	26.6k
Tania Roskams	6.6k 0.8×	11.6k 1.5×	8.5k 1.3×	4.7k 0.8×	1.7k 0.3×	428	25.9k
Ralf Weiskirchen	6.0k 0.7×	6.5k 0.8×	7.0k 1.0×	1.7k 0.3×	2.6k 0.5×	489	19.0k
Mathias Heikenwälder	8.8k 1.0×	3.0k 0.4×	4.4k 0.6×	3.7k 0.6×	6.8k 1.4×	224	21.6k
Emma E. Furth	5.8k 0.7×	2.4k 0.3×	2.9k 0.4×	3.9k 0.6×	1.7k 0.3×	253	15.1k

Countries citing papers authored by Jesús Prìeto

Since Specialization

Citations

This map shows the geographic impact of Jesús Prìeto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Prìeto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Prìeto more than expected).

Fields of papers citing papers by Jesús Prìeto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Prìeto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Prìeto. The network helps show where Jesús Prìeto may publish in the future.

Co-authorship network of co-authors of Jesús Prìeto

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Prìeto. A scholar is included among the top collaborators of Jesús Prìeto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Prìeto. Jesús Prìeto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Merino, María, Lei Jiang, Ana Sampedro, et al.. (2022). Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria. Science Translational Medicine. 14(627). eabc0700–eabc0700. 12 indexed citations

Zabaleta, Nerea, Mirja Hommel, Rubén Hernández-Alcoceba, et al.. (2017). Improvement of Adeno-Associated Virus-Mediated Liver Transduction Efficacy by Regional Administration in Macaca fascicularis. 28(2). 68–73. 8 indexed citations

Prìeto, Jesús, et al.. (2017). Assessment of Biliary Bicarbonate Secretion in Humans by Positron Emission Tomography. Revista de medicina de la Universidad de Navarra. 64–64. 24 indexed citations

Su, Li, Yongli Luo, Zhi Yang, et al.. (2016). MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer. Cancer Research. 76(17). 5054–5067. 57 indexed citations

Scala, Marianna Di, Eduardo Salido, Esperanza López‐Franco, et al.. (2016). Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis. The Journal of Immunology. 197(6). 2145–2156. 24 indexed citations

Ma, Leina, Jia Liu, Limei Liu, et al.. (2014). Overexpression of the Transcription Factor MEF2D in Hepatocellular Carcinoma Sustains Malignant Character by Suppressing G2–M Transition Genes. Cancer Research. 74(5). 1452–1462. 74 indexed citations

Ochoa, María C., Jessica Fioravanti, Inmaculada Rodríguez, et al.. (2012). Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein. Cancer Research. 73(1). 139–149. 39 indexed citations

Aranda, Fernando, Diana Llópiz, Nancy Díaz‐Valdés, et al.. (2011). Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors. Cancer Research. 71(9). 3214–3224. 63 indexed citations

Rodríguez‐Ortigosa, Carlos M., Jesús M. Bañales, Iker Uriarte, et al.. (2010). Biliary secretion of S‐nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat†. Hepatology. 52(2). 667–677. 17 indexed citations

10.

Perugorria, María J., Josefa Castillo, María U. Latasa, et al.. (2009). Wilms' Tumor 1 Gene Expression in Hepatocellular Carcinoma Promotes Cell Dedifferentiation and Resistance to Chemotherapy. Cancer Research. 69(4). 1358–1367. 46 indexed citations

11.

Hu, Jie, Aiwen Dong, Juanjuan Shan, et al.. (2009). Blockade of Wnt Signaling Inhibits Angiogenesis and Tumor Growth in Hepatocellular Carcinoma. Cancer Research. 69(17). 6951–6959. 105 indexed citations

12.

Montero, Joan, Albert Morales, Laura Llacuna, et al.. (2008). Mitochondrial Cholesterol Contributes to Chemotherapy Resistance in Hepatocellular Carcinoma. Cancer Research. 68(13). 5246–5256. 232 indexed citations

13.

Rodríguez-Madoz, Juan R., Pilar Alzuguren, M. Gabriela Kramer, et al.. (2006). Increased Efficacy and Safety in the Treatment of Experimental Liver Cancer with a Novel Adenovirus-Alphavirus Hybrid Vector. Cancer Research. 66(3). 1620–1629. 28 indexed citations

14.

Tirapu, Iñigo, Eduardo Huarte, Cristiana Guiducci, et al.. (2006). Low Surface Expression of B7-1 (CD80) Is an Immunoescape Mechanism of Colon Carcinoma. Cancer Research. 66(4). 2442–2450. 116 indexed citations

15.

Fortes, Puri, Yolanda Cuevas, Fei Guan, et al.. (2003). Inhibiting expression of specific genes in mammalian cells with 5′ end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA. Proceedings of the National Academy of Sciences. 100(14). 8264–8269. 69 indexed citations

16.

Melero, Ignacio, Iñigo Tirapu, Ainhoa Arina, et al.. (2003). Anti-ICAM-2 monoclonal antibody synergizes with intratumor gene transfer of interleukin-12 inhibiting activation-induced T-cell death.. PubMed. 9(10 Pt 1). 3546–54. 7 indexed citations

17.

Melero, Ignacio, Ángel L. Corbí, Miguel Relloso, et al.. (2002). An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomas.. PubMed. 62(11). 3167–74. 17 indexed citations

18.

Medina, Juan F., Eduardo Martínez‐Ansó, J. J. Vázquez, & Jesús Prìeto. (1997). Decreased Anion Exchanger 2 Immunoreactivity in the Liver of Patients With Primary Biliary Cirrhosis. Hepatology. 25(1). 12–17. 148 indexed citations

19.

Domenech, Pilar, et al.. (1995). Cloning and expression of theMycobacterium fortuitumSuperoxide dismutase gene. FEMS Microbiology Letters. 134(2-3). 273–278. 11 indexed citations

20.

Beloqui, Óscar, Jesús Prìeto, José Antonio Suárez, et al.. (1993). N -Acetyl Cysteine Enhances the Response to Interferon-α in Chronic Hepatitis C: A Pilot Study. Journal of Interferon Research. 13(4). 279–282. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact